The most common growth-factor pathways that seem to be activated in specific types of sarcomas include the insulin-like growth factor 1 (IGF1)-receptor [17,18], the PDGFR [15,19], the c-KIT receptor [20,21], and the c-MET-receptor [22,23]. This evidence concerns the gene PDGFRB and sarcoma.